Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Year-over-year book value per share growth
Latest
-92.19%
↓ 16096% vs avg
Percentile
P3
Near historical low
Streak
4 qtr
Consecutive declineDecelerating
Average
-0.57%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -92.19% |
| Q2 2025 | -40.55% |
| Q1 2025 | -39.32% |
| Q4 2024 | -33.06% |
| Q3 2024 | -4.49% |
| Q2 2024 | -36.81% |
| Q1 2024 | -16.95% |
| Q4 2023 | -9.89% |
| Q3 2023 | -4.73% |
| Q2 2023 | -3.85% |
| Q1 2023 | -9.63% |
| Q4 2022 | -5.16% |
| Q3 2022 | -14.56% |
| Q2 2022 | -2.69% |
| Q1 2022 | -11.39% |
| Q4 2021 | -10.60% |
| Q3 2021 | -7.20% |
| Q2 2021 | -9.30% |
| Q1 2021 | -9.36% |
| Q4 2020 | -8.38% |
| Q3 2020 | -8.64% |
| Q2 2020 | -9.55% |
| Q1 2020 | 79.51% |
| Q4 2019 | -9.37% |
| Q3 2019 | -8.00% |
| Q2 2019 | 452.60% |
| Q1 2019 | -144.11% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |